Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
52.91
+0.91 (1.75%)
At close: Dec 20, 2024, 4:00 PM
52.66
-0.25 (-0.47%)
After-hours: Dec 20, 2024, 6:26 PM EST
Tarsus Pharmaceuticals Employees
Tarsus Pharmaceuticals had 244 employees as of December 31, 2023. The number of employees increased by 157 or 180.46% compared to the previous year.
Employees
244
Change (1Y)
157
Growth (1Y)
180.46%
Revenue / Employee
$531,234
Profits / Employee
-$550,586
Market Cap
2.02B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 244 | 157 | 180.46% |
| Dec 31, 2022 | 87 | 41 | 89.13% |
| Dec 31, 2021 | 46 | 26 | 130.00% |
| Dec 31, 2020 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| PACS Group | 32,433 |
| Omnicell | 3,650 |
| Alignment Healthcare | 1,536 |
| Supernus Pharmaceuticals | 652 |
| TransMedics Group | 584 |
| Agios Pharmaceuticals | 386 |
| Wave Life Sciences | 268 |
| Mirum Pharmaceuticals | 264 |
TARS News
- 6 days ago - Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison's Top 2 Picks - Seeking Alpha
- 5 weeks ago - Tarsus Pharmaceuticals, Inc. (TARS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors - GlobeNewsWire
- 6 weeks ago - Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024 - GlobeNewsWire
- 6 weeks ago - Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer - GlobeNewsWire
- 2 months ago - Tarsus Launches “Your Mitey Problem,” the First Direct-to-Consumer TV Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% - GlobeNewsWire
- 3 months ago - Tarsus to Participate in Fireside Chat at UBS Virtual Ophthalmology Day 2024 - GlobeNewsWire
- 3 months ago - Tarsus Pharmaceuticals: Unlocking Growth Potential With Eye Care Innovations - Seeking Alpha